NT5E and breast cancer: Cyclin D1 was involved in the AKT–glycogen synthase kinase 3 β–β‐catenin–cyclin D1 signaling pathway that participated in the process of extracellular 5′‐nucleotidase (CD73) promotion of cell growth of human breast cancer 25.